ANI Pharmaceuticals, Inc. (ANIP)
81.39
-0.38
(-0.46%)
USD |
NASDAQ |
Dec 08, 16:00
81.39
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Research and Development Expense (TTM): 56.05M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 12.46M |
| Arcutis Biotherapeutics, Inc. | 71.08M |
| Intellia Therapeutics, Inc. | 407.11M |
| Beam Therapeutics, Inc. | 411.79M |
| Halozyme Therapeutics, Inc. | 70.03M |